The tweet was deleted by the author.
But we saved everything 🙂.
Caribou Biosciences is set to have its president and CEO, Rachel Haurwitz, PhD, participate in an upcoming fireside chat at the Bank of America Securities Health Care Conference.
The discussion will be accessible via webcast, providing insights into the company’s strategy within the cell therapy and CRISPR sectors. Caribou Biosciences continues to engage stakeholders and the broader biotech community through such high-profile industry events.
Caribou Biosciences CEO Rachel Haurwitz previously addressed advances in biotechnology at the BofA Securities Health Care Conference in Las Vegas. Her participation in industry events has highlighted the company’s presence within the biotech sector. Caribou Biosciences continues to engage with investors and peers through these conference platforms.